However, while this has never been explored in AML, studies suggest fatty acid desaturation may be crucial to therapeutic resistance in other cancers: increased unsaturated fatty acids have been observed in cancer stem cells, and the inhibition of stearoyl-CoA desaturase-1 (SCD-1) results in decreased proliferation [15]. The gene discussed is SCD; the disease is cancer.